Announced Fri, 16 Jan · 18:19 IST
AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Compliance View source PDF
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
AstraZeneca Pharma India Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory compliance filing with no specific financial details disclosed. Such certificates are typically submitted by companies to confirm compliance with depository-related requirements for their securities.
Likely market impact
This is a standard compliance filing and is not expected to have any material impact on the stock price or shareholder value. It reflects the company adhering to routine regulatory obligations.